NewsNTech
The scaling phase of a wireless medical device program is where the capital bill accelerates.
Once the engineering work is done, building clinical relationships, training hospital users, and converting initial placements into contracted revenue can consume more capital than the device development itself.
Xenter, the Draper, Utah company operating the TechMed™ platform, closed a $58.25 million Series B on July 16, 2026, directing the proceeds at that specific phase.
XenFi and the TechMed stack The announcement centers the raise on three areas: the commercial launch of XenFi™, continued innovation of wireless medical devices and technologies, and the AI-Enabled Physical Intelligence™ platform.
Keep reading